Evidence map›Paper›PMID 33298420›Full record

ReviewDiabetes care2021

9. Pharmacologic Approaches to Glycemic Treatment:

American Diabetes Association

3 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT05343767. Cited by 518 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
518citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05343767 nacompleted

A Phase II, Randomized, Double Blind, Double Dummy, Active-Controlled Clinical Trial to Investigate the Efficacy and Safety of Low-Glu in Patients Newly Diagnosed With Type II Diabetes Mellitus

Ran2018Enrolled198Registered outcomes6Posted comparisons0ConditionsType2 Diabetes MellitusArmsMetformin, Natural Wellness Low-Glu high dose, Natural Wellness Low-Glu low dose
PMID 11742409PMID 18066129PMID 18801863PMID 18672036PMID 9686693PMID 9506190PMID 30873688PMID 19464860PMID 19699773PMID 19734396PMID 19875552PMID 19896746other papers from this trial
Open the trial in the graph
NCT04862858 naunknown statusnot on this map

Improving Outcomes in Patients With Comorbid T2DM and ASCVD: Population Health Management Interventions Supporting Guideline-recommended SGLT2i and GLP-1 RA Medications

TypeinterventionalSponsorHumana Inc.Ran2021 to 2022Enrolled4,197ConditionsDiabetes Mellitus, Type 2, Cardiovascular DiseasesArmsEducational Intervention
NCT05349955 narecruitingnot on this mapstarted 2022, after this paper: background citation

Effects and Safety of GUideline Algorithm Based Intervention on CaRdiovascular and Renal Outcomes in Elderly Diabetic Patients With High Cardiovascular Risk in the Community- A Cluster Randomized Controlled Trial (GUARD-Community Study)

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2022 to 2026Enrolled5,600ConditionsType 2 Diabetes, Cardiovascular Complication, Diabetic Kidney DiseaseArmsIntensive guideline algorithm implementation, Conventional guideline algorithm implementation
3 · Its place in the literature

Who cites it

518 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. iScience · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

458 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

American Diabetes Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc21-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Indexed as

Diabetes MellitusEndocrinologyBlood GlucoseHumansSocieties, MedicalStandard of CareBlood Glucose

Identifiers

PMID33298420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.